81
55
Growth Score
-5 pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
2598686
Integrative Enzymatics has developed a proprietary method of designing pharmaceuticals.
About the Company
Integrative Enzymatics is a biotechnology company dedicated to developing structure-based pharmaceutical products to treat chronic metabolic disorders. The company’s primary offering is an intellectual property portfolio that consists of two drugs used for the treatment of Type I Diabetes Mellitus and Type II Diabetes Mellitus. The efficacy of both
pharmaceuticals have been demonstrated in silico, in vitro, and verified through pilot animal studies. Second round animal trials are ongoing.
Integrative Enzymatics has developed a proprietary method of designing pharmaceuticals. Their flagship patented drug treats diabetes.
